says that the clearance will see Boston Scientific consolidate its market position given its “already a major player in the percutaneous transluminal angioplasty (PTA) balloon catheter and ...

Boston Scientific (NYSE: BSX) today announced positive 12-month study results for its Farapulse pulsed field ablation (PFA) ...

The study enrolled 255 subjects across 29 sites in the US, with 141 subjects undergoing CTI ablation with the Farapoint PFA catheter for AFL. Boston Scientific AF Solutions chief medical officer ...

Abbott designed the Volt PFA catheter for maneuverability, efficient ablation and thermal risk mitigation, said Dr.

Boston Scientific Corporation has entered a definitive agreement to acquire the remaining 74% stake not yet owned in Bolt Medical, in a deal valued at up to $664m. The acquisition includes nearly ...